Related Experiment Video

Updated: May 24, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Acute lead poisoning in an infant

M Madhusudhanan, S B Lall

    Oman Medical Journal
    |March 9, 2012
    PubMed

    Insights

    Acute lead poisoning in an infant was diagnosed in Oman using X-rays and high blood lead levels. Early detection and treatment with calcium edetate (EDTA) therapy prevented complications.

    Area of Science:

    • Toxicology
    • Pediatrics
    • Environmental Health

    Background:

    • Acute lead poisoning in infants can occur without obvious neurological symptoms.
    • Traditional remedies are a potential source of heavy metal exposure in children.

    Observation:

    • A case in Oman involved an infant diagnosed with lead poisoning via abdominal X-rays and elevated blood lead levels (83.3 µg/dL).
    • The infant received a traditional remedy containing 20.2% inorganic lead for constipation.
    • Radio-opaque speckles were visible on the infant's abdominal X-ray.

    Findings:

    • Treatment with intravenous calcium edetate (EDTA) effectively reduced blood lead levels.
    • Prompt diagnosis and intervention mitigated potential encephalopathy and long-term sequelae.

    Implications:

    • Highlights the importance of considering lead poisoning in infants presenting with non-specific symptoms.
    • Underscores the need for parental education on the risks associated with traditional remedies.
    • Emphasizes the critical role of toxicology screening in diagnosing environmental exposures.

    More Related Videos

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

    Published on: October 31, 2025

    A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy10:30

    A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

    Published on: May 16, 2015

    Related Concept Videos

    Anticholinesterase Agents: Poisoning and Treatment01:26

    Anticholinesterase Agents: Poisoning and Treatment

    Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
    Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
    Prevention of Further Absorption of Poison01:14

    Prevention of Further Absorption of Poison

    In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
    Hepatic Encephalopathy01:29

    Hepatic Encephalopathy

    DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmaceutical Poisoning: Treatment Strategies01:26

    Pharmaceutical Poisoning: Treatment Strategies

    Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...